B&L launches new stable tubing system

Article

Bausch & Lomb has introduced a stable chamber tubing system, as a part of the new micro incision vacuum pack, to its Millennium Micro Incision Cataract Surgery (MICS) platform.

Bausch & Lomb has introduced a stable chamber tubing system, as a part of the new micro incision vacuum pack, to its Millennium Micro Incision Cataract Surgery (MICS) platform.

As part of the company's ongoing strategy to provide safe and effective 1.8 mm phacoemulsification, the stable chamber tubing system was designed to maintain positive intraocular pressure (IOP) during surgery and to provide surge-free phaco surgery at high vacuums. To achieve this, small diameter tubing is used to create resistance to flow throughout the entire fluidic circuit. A filter is integrated into the aspiration tubing which captures particles larger than 0.5 mm, yet still allows the free flow of fluid, preventing clogging.

Other features of the Millennium MICS platform include the new custom control software which offers five ultrasounding options helping to minimize ?absolute phaco time', reducing heat generation and thus increasing safety.

To support surgeons' transitions to 1.8 mm surgery, Bausch & Lomb has set up the Millennium MICS education programme.

Ophthalmology Times Europe reporting from the XXIV Congress of the ESCRS, London, 9-13 September, 2006.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
© 2025 MJH Life Sciences

All rights reserved.